Drug recall
Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pharmacy…
FDA recall event 76235 · Class II · MOORE'S COMPOUNDING PHARMACY
Key facts
| Event ID | 76235 |
|---|---|
| Recall numbers | D-0488-2017 |
| Recalling firm | MOORE'S COMPOUNDING PHARMACY |
| Product type | Drugs |
| Products | Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pharmacy Compounding, Corpus Christi, TX |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Superpotent Drug and Subpotent Drug; potency failures obtained |
| Initiation date | Sep 12, 2016 |
| Report date | Mar 1, 2017 |
| Termination date | May 17, 2017 |
| City | Corpus Christi |
| State | TX |
| Country | United States |
| FEI number | 3011759873 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: